Literature DB >> 17336146

Abnormal intracortical facilitation in early-stage Huntington's disease.

R Nardone1, P Lochner, R Marth, H Ausserer, A Bratti, F Tezzon.   

Abstract

OBJECTIVE: It is known from neuropathological and imaging studies that the neuronal degeneration in Huntington's disease (HD) is already quite severe when the first symptoms of the disease become clinically evident. This study was aimed at detecting neurophysiological changes, as assessed by means of transcranial magnetic stimulation (TMS), involved in the early pathogenesis of the neurodegeneration in HD.
METHODS: Motor cortex excitability was examined in 12 patients with HD in the early clinical stage of the disease and in 15 age-matched control subjects, using a range of TMS protocols. Central motor conduction time, resting and active motor threshold, duration of the cortical silent period, the short-interval paired-pulse intracortical inhibition (SICI) and the paired-pulse intracortical facilitation (ICF) were examined.
RESULTS: The early-stage HD patients showed a statistically significant reduction in ICF. The other measures did not differ significantly from the control subjects.
CONCLUSIONS: Our findings provide neurophysiological evidence that changes in motor function are present in the early HD. Since ICF is thought to depend upon the activity of intracortical glutamatergic excitatory circuits, the results of our study support the theory that altered NMDA receptor function plays an important role in the pathogenesis of HD. SIGNIFICANCE: These findings may provide clues to the underlying pathophysiology of the disease. A more complete understanding of the changes in motor cortex excitability that occur early in the course of HD will lead to a better definition of the disease process and may allow earlier diagnosis and intervention.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17336146     DOI: 10.1016/j.clinph.2007.01.009

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  6 in total

1.  Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity.

Authors:  H Diana Rosas; David H Salat; Stephanie Y Lee; Alexandra K Zaleta; Vasanth Pappu; Bruce Fischl; Doug Greve; Nathanael Hevelone; Steven M Hersch
Journal:  Brain       Date:  2008-03-12       Impact factor: 13.501

Review 2.  Developmental origins of cortical hyperexcitability in Huntington's disease: Review and new observations.

Authors:  Carlos Cepeda; Katerina D Oikonomou; Damian Cummings; Joshua Barry; Vannah-Wila Yazon; Dickson T Chen; Janelle Asai; Christopher K Williams; Harry V Vinters
Journal:  J Neurosci Res       Date:  2019-07-28       Impact factor: 4.164

3.  Changes of motor cortical excitability and response inhibition in patients with obsessive–compulsive disorder

Authors:  Jee In Kang; Deog Young Kim; Chang-il Lee; Chan-Hyung Kim; Se Joo Kim
Journal:  J Psychiatry Neurosci       Date:  2019-07-01       Impact factor: 6.186

Review 4.  Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.

Authors:  Steve Vucic; Matthew C Kiernan
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

5.  Abnormal motor cortex excitability in preclinical and very early Huntington's disease.

Authors:  Sven Schippling; Susanne A Schneider; Khailash P Bhatia; Alexander Münchau; John C Rothwell; Sarah J Tabrizi; Michael Orth
Journal:  Biol Psychiatry       Date:  2009-02-07       Impact factor: 13.382

Review 6.  Anatomo-Functional Origins of the Cortical Silent Period: Spotlight on the Basal Ganglia.

Authors:  David Zeugin; Silvio Ionta
Journal:  Brain Sci       Date:  2021-05-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.